[{"NetIncomeLoss_2_Q2_USD":115433000.0,"PaymentsToAcquireInvestments_2_Q2_USD":433154000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":105894000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":7840000.0,"InventoryFinishedGoods_0_Q2_USD":5086000.0,"ContractWithCustomerAssetNetCurrent_0_Q2_USD":13800000.0,"InterestIncomeOther_1_Q2_USD":5162000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":839318.0,"InterestIncomeOther_2_Q2_USD":12382000.0,"InventoryGross_0_Q2_USD":22237000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8062000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":4771000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":17938000.0,"Liabilities_0_Q2_USD":213224000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":548973000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":48334000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":19148000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"ShareBasedCompensation_2_Q2_USD":30136000.0,"Assets_0_Q2_USD":2046548000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":1031530000.0,"CommonStockSharesIssued_0_Q2_shares":308886497.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":17955000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":13783000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":20941000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":9221000.0,"ContractWithCustomerLiability_0_Q2_USD":16300000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":59791000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":122731000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-726000.0,"AssetsCurrent_0_Q2_USD":1394663000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":151000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":18510000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":527143000.0,"OtherAssetsNoncurrent_0_Q2_USD":60502000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":262000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":13875000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":25298000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":0.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":6000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":316992000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":318144000.0,"CommonStockValue_0_Q2_USD":309000.0,"InventoryWriteDown_2_Q2_USD":1300000.0,"EarningsPerShareBasic_2_Q2_USD":0.38,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":110872000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":151000.0,"InventoryRawMaterials_0_Q2_USD":1876000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":114933000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":216810000.0,"EarningsPerShareBasic_1_Q2_USD":0.22,"Revenues_1_Q2_USD":259479000.0,"Revenues_2_Q2_USD":486394000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q2_investment":17.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":33156000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":74883000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":120204000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"IncreaseDecreaseInInventories_2_Q2_USD":7049000.0,"RestrictedCashEquivalentsNoncurrent_0_Q2_USD":1636000.0,"CostsAndExpenses_1_Q2_USD":183945000.0,"CostsAndExpenses_2_Q2_USD":358051000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-3003000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.172,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.18,"RevenueRemainingPerformanceObligation_0_Q2_USD":71400000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":4376000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_0_Q2_USD":311441000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"ShortTermInvestments_0_Q2_USD":685895000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":148235000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":9.74,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":528779000.0,"AccountsPayableCurrent_0_Q2_USD":9103000.0,"LiabilitiesCurrent_0_Q2_USD":142681000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":720089000.0,"InventoryWorkInProcess_0_Q2_USD":15275000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":307807000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":43937000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":306598000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":25215000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":30136000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":16154000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":20941000.0,"Goodwill_0_Q2_USD":63684000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":10386000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":157751000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":4771000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":22793000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"NetIncomeLoss_1_Q2_USD":66821000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":52323000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":0.0,"ReceivablesNetCurrent_0_Q2_USD":121080000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":1346000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":2287000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":32830000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":804000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":35318000.0,"InterestReceivable_0_Q2_USD":5300000.0,"AdditionalPaidInCapital_0_Q2_USD":2269093000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":10337000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":10394000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":8062000.0,"ContractWithCustomerLiabilityRevenueRecognized_2_Q2_USD":3400000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q2_USD":62000000.0,"PreferredStockValue_0_Q2_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.4,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":1300000.0,"InventoryNet_0_Q2_USD":16608000.0,"CustomerRefundLiabilityCurrent_0_Q2_USD":16957000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":80696000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2046548000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":140731000.0,"OperatingIncomeLoss_1_Q2_USD":75534000.0,"OperatingIncomeLoss_2_Q2_USD":128343000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":259479000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":486394000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":18954000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":25749356.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":30136000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":16154000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_2_Q2_USD":82200000.0,"EarningsPerShareDiluted_2_Q2_USD":0.36,"EarningsPerShareDiluted_1_Q2_USD":0.21,"CommonStockSharesOutstanding_0_Q2_shares":308886497.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2014000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":260642000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-443918000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16655274.0,"LongTermInvestments_0_Q2_USD":327141000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":1021295000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":9925000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":15003000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"StockholdersEquity_0_Q2_USD":1833324000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":7206000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":9659000.0,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]